If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

Share Price is delayed by 15 minutes
Get Live Data
420.00    2.00 (0.48%)
Bid:
420.00
Ask:
422.00
Spread: 2.00 (0.476%)
Market Cap: £532.88m
NAS Live PriceLast checked at - London Stock Exchange

Intraday North Atl.smlr Share Chart

Statement re Shareholder Engagement

20 Dec 2022 07:00

RNS Number : 2208K
North Atlantic Smlr Co Inv Tst PLC
20 December 2022
 

North Atlantic Smaller Companies Investment Trust PLC

(the "Company")

 

20 December 2022

 

 

Further to the Company's Results of Annual General Meeting announcement on 21 June 2022, the Company announced that over 20% of shareholders voting on resolution 14 concerning the waiver of Rule 9 had voted against the resolution. Resolution 14 was put to the Meeting as a resolution of the independent shareholders of the Company. As a result, 9,455,336 of the ordinary shares in issue were eligible to vote on this resolution, these shares not being held by the Concert Party (as defined in the Notice of AGM). The waiver of Rule 9 granted by Resolution 14 permits the Concert Party's interest in the Company's shares to increase from 30.78% to a maximum of 34.21% (in each case representing 4,205,664 ordinary shares) as a result of the share buyback authorised by Resolution 12 without requiring the Concert Party to make a mandatory offer for the other shareholders' shares. 

 

Under the FRC's UK Corporate Governance Code, companies receiving such a vote against a resolution should publish, no later than six months after the shareholder meeting, an update on the views received from shareholders and actions taken by the Company. 

 

Following an extensive analysis of the Company's Shareholder Register, the Company have established that the majority of the voting shares received against the waiver of Rule 9 are held in nominee accounts, many of which rely on shareholder advisory consultants to determine their voting. This means that underlying investors are recommended to vote against share buybacks in principle as the shareholder advisory consultants are concerned about what they see as the Concert Party's potential creeping control of the Company. Whilst this is a valid concern for a trading company, the Directors do not believe this is so for an investment trust.

 

The Board have been working to positively engage with the underlying Shareholders and are accelerating their Investor Relations efforts in this regard and continue to do so. The Directors expect to commence a further outreach campaign to engage with any dissenting Shareholders in the coming months and to help resolve any concerns they may have. The outcome of this initiative will be published in the Company's Annual Report next spring. In the meantime, the Board believe that it is overwhelmingly in the best interest of all Shareholders that the buyback programme continues. 

 

 

 

Contact:

Kin Company Secretarial Limited, Company Secretary

020 8819 6486

companysecretary@kincosec.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRQKLFFLLLLFBD
Date   Source Headline
4th Jul 20163:19 pmRNSDirector/PDMR Shareholding
28th Jun 20163:55 pmRNSAGM Statement
14th Jun 201610:02 amRNSNet Asset Value(s)
27th May 20169:47 amRNSAnnual Financial Report
17th May 20169:55 amRNSNet Asset Value(s)
12th May 20166:33 pmRNSFinal Results
11th May 20162:56 pmRNSTransaction in Own Shares
12th Apr 20168:40 amRNSNet Asset Value(s)
14th Mar 201611:47 amRNSNet Asset Value(s)
24th Feb 201611:26 amRNSHolding(s) in Company
15th Feb 201611:14 amRNSNet Asset Value(s)
1st Feb 201611:50 amRNSTransactions in Close Period
19th Jan 201611:19 amRNSDirector/PDMR Shareholding
13th Jan 20164:20 pmRNSNet Asset Value(s)
11th Dec 201512:31 pmRNSNet Asset Value(s)
26th Nov 201511:03 amRNSDirectorate Change
16th Nov 201511:38 amRNSPortfolio Update
10th Nov 20152:26 pmRNSNet Asset Value(s)
5th Nov 201510:48 amRNSTransaction in Own Shares
2nd Nov 201510:38 amRNSHolding(s) in Company
12th Oct 201512:26 pmRNSNet Asset Value(s)
2nd Oct 201512:44 pmRNSHolding(s) in Company
16th Sep 20159:17 amRNSDeath of a Director
15th Sep 20159:54 amRNSNet Asset Value(s)
10th Sep 20156:15 pmRNSHalf Yearly Report
10th Sep 20154:34 pmRNSHolding(s) in Company
12th Aug 201512:46 pmRNSNet Asset Value(s)
17th Jul 20159:39 amRNSNet Asset Value(s)
14th Jul 20159:36 amRNSDirector/PDMR Shareholding
9th Jul 201512:28 pmRNSPortfolio Update
30th Jun 20152:12 pmRNSResult of AGM
11th Jun 20153:31 pmRNSNet Asset Value(s)
26th May 20152:32 pmRNSDoc re. Annual Report
14th May 20156:12 pmRNSFinal Results
13th May 201511:24 amRNSNet Asset Value(s)
29th Apr 201510:11 amRNSHolding(s) in Company
14th Apr 201510:08 amRNSNet Asset Value(s)
2nd Apr 20159:05 amRNSDirector/PDMR Shareholding
1st Apr 20159:21 amRNSDirector/PDMR Shareholding
23rd Mar 201512:43 pmRNSHolding(s) in Company
18th Mar 20153:32 pmRNSNet Asset Value(s)
5th Mar 20159:28 amRNSTransactions in Close Period
2nd Mar 20159:35 amRNSHolding(s) in Company
12th Feb 20155:56 pmRNSNet Asset Value(s)
15th Jan 201510:59 amRNSNet Asset Value(s)
15th Dec 201410:03 amRNSNet Asset Value(s)
10th Dec 20145:13 pmRNSHolding(s) in Company
17th Nov 201410:01 amRNSNet Asset Value(s)
28th Oct 20145:08 pmRNSDirector/PDMR Shareholding
13th Oct 201412:21 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.